Successful Treatment of Early Relapse in Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin and HLA-Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

Abematsu Takanari; Nishikawa Takuro; Nakagawa Shunsuke; Kodama Yuichi; Okamoto Yasuhiro; Kawano Yoshifumi

首页> 外文期刊>Pediatric blood & cancer >Successful Treatment of Early Relapse in Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin and HLA-Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

【24h】

Successful Treatment of Early Relapse in Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin and HLA-Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

机译：使用移植后环磷酰胺的inotuzumab ozogamicin和HLA-Haploidentical干细胞移植的急性淋巴细胞白血病早期复发的成功治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2019年第s5期|共2页
作者
Abematsu Takanari; Nishikawa Takuro; Nakagawa Shunsuke; Kodama Yuichi; Okamoto Yasuhiro; Kawano Yoshifumi;
展开▼
作者单位

Kagoshima Univ Hosp Dept Pediat Kagoshima Japan;

Kagoshima Univ Hosp Dept Pediat Kagoshima Japan;

Kagoshima Univ Hosp Dept Pediat Kagoshima Japan;

Kagoshima Univ Hosp Dept Pediat Kagoshima Japan;

Kagoshima Univ Hosp Dept Pediat Kagoshima Japan;

Kagoshima Univ Hosp Dept Pediat Kagoshima Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. Successful Treatment of Early Relapse in Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin and HLA-Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide [J] . Abematsu Takanari, Nishikawa Takuro, Nakagawa Shunsuke, Pediatric blood & cancer . 2019,第S5期

机译：使用移植后环磷酰胺的inotuzumab ozogamicin和HLA-Haploidentical干细胞移植的急性淋巴细胞白血病早期复发的成功治疗
2. Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [J] . Ilina Micheva, Vladimir Gerov, Stela Dimitrova, Case Reports in Hematology . 2021,第a期

机译：inotuzumab ozogamicin加ponatinib的功效随后在患有费城染色体阳性急性淋巴细胞白血病患者中的同种异体干细胞移植
3. Role of Remission Status and Prior Transplant in Optimizing Survival Outcomes Following Allogeneic Hematopoietic Stem Transplantation (HSCT) in Patients Who Received Inotuzumab Ozogamicin for Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) [J] . Partow Kebriaei, Matthias Stelljes, Daniel J. DeAngelo, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：缓解状态的作用及以前移植在接受inotuzumab ozogamicin的同种异体造血干膜移植（HSCT）后的存活结果进行复发/难治（R / R）急性淋巴细胞白血病（全部）
4. Vasoactive Intestinal Polypeptide Induces Regulatory Dendritic Cells Thai Prevent Acute Graft Versus Host Disease and Leukemia Relapse after Bone Marrow Transplantation [C] . MARIO DELGADO, ALEJO CHORNY, DOINA GANEA, International Symposium on VIP, PACAP, and Related Peptides . 2006

机译：血管活性肠道多肽诱导调节性树突细胞泰国预防急性移植物与骨髓移植后宿主病和白血病复发
5. Retrospective analysis of survival and treatment related mortality following a myeloablative hematopoietic stem cell transplant in childhood acute lymphoblastic leukemia. [D] . Dasgupta, Sreejeta. 2010

机译：儿童急性淋巴细胞白血病清髓性造血干细胞移植后生存和治疗相关死亡率的回顾性分析。
6. Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [O] . Ilina Micheva, Vladimir Gerov, Stela Dimitrova, 2021

机译：inotuzumab ozogamicin加ponatinib的功效随后在患有费城染色体阳性急性淋巴细胞白血病患者中的同种异体干细胞移植
7. Successful treatment of extramedullary relapsed/refractory B-acute lymphoblastic leukemia with Inotuzumab ozogamicin before and after allogeneic stem cell transplantation [O] . Anna G. Smirnova, Sergey N. Bondarenko, Ivan S. Moiseev, 2019

机译：同种异体干细胞移植前后用Inotuzumab ozogamicin成功治疗髓质复发/难治性B急性淋巴细胞白血病

Successful Treatment of Early Relapse in Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin and HLA-Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

著录项

相似文献

相关主题

期刊订阅